Inhibition of the defense system stimulating interleukin-12 lnterferon- γ pathway during critical i11ness

Blood

Volumn 89, Issue 5, 1997, Pages 1612-1620

  Ertel, Wolfgang ^a   Keel, Marius ^b   Neidhardt, Regula ^b   Steekholzer, Ursula ^b   Kremer, Jean Pierre ^b   Ungethuem, Udo ^b   Trentz, Otmar ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12;

ARTICLE; CELL ADHESION; CELL COMPARTMENTALIZATION; CRITICAL ILLNESS; CYTOLYSIS; ENDOTOXEMIA; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; KILLER CELL; MACROPHAGE FUNCTION; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION;

EID: 0031018429     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.5.1612     Document Type: Article

References (42)

1. Trinchieri G: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251, 1995
2. Farrar MA, Schreiber RD: The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 11:571, 1993
3. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E, Chizzonite R, Wolf SF, Trinchieri G: Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J Exp Med 176:1387, 1992
4. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G: Induction of interferon gamma production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J Exp Med 173:869, 1991
5. Cassatella MA, Meda L, Gasperini S, D'Andrea A, Ma X, Trinchieri G: Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immnnol 25:1, 1995
6. Kubin M, Chow JM, Trinchieri G: Differential regulation of interleukin-12 (IL-12), tumor necrosis factor α, and IL-1β production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 83:1847, 1994
7. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A: Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 90:6115, 1993
8. Bohn E, Heesemann J, Ehlers S, Authenrieth IB: Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica. Infect Immun 62:3027, 1994
9. Hunter CA, Candolfi E, Subauste C, Van Cleave V, Remington JS: Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 84:16, 1995
10. Tripp CS, Gately MK, Hakimi J, Ling P, Unanue ER: Neutralization of IL-12 decreases resistance to Lisreria in SCID and C.B-17 mice. Reversal by IFN-gamma. J Immunol 152:1883, 1994
11. O'Suilleabhain C, O'Sullivan ST, Kelly JL, Lederer J, Mannick JA, Rodrick ML: Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery 120:290, 1996
12. Rodrick ML, Wood JJ, O'Mahony JB, Davis CF, Grbic JT, Demling RH, Moss NM, Saporoschetz I, Jordan A, D'Eon P: Mechanisms of immunosuppression associated with severe nonthermal traumatic injuries in man: Production of interleukin 1 and 2. J Clin Immunol 6:310, 1986
13. Faist E, Schinkel C, Zimmer S, Kremer JP, Von Donnersmarck GH, Schildberg FW: Inadequate interleukin-2 synthesis and interleukin-2 messenger expression following thermal and mechanical trauma in humans is caused by defective transmembrane signalling. J Trauma 34:846, 1993
14. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW: Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341, 1995
15. Greenspan L, McLellan BA, Greig H: Abbreviated injury scale and injury severity score: A scoring chart. J Trauma 25:60, 1985
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: A severity of disease classification system. Crit Care Med 13:818, 1985
17. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA: Sepsis syndrome: A valid clinical entity. Methylprednisolone severe sepsis study group. Crit Care Med 17:389. 1989
18. Ling P, Gately MK, Gubler U, Stern AS, Lin P, Hollfelder K, Su C, Pan YC, Hakimi J: Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 154:116, 1995
19. 1 inhibits synthesis of cytokines in endotoxin stimulated human whole blood. Arch Surg 1996 (in press)
20. Abrams JS, Roncarolo MG, Yssel H, Andersson U, Gleich GJ, Silver JE: Strategies of anti-cytokine monoclonal antibody development: Immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 127:5, 1992
21. Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G: The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J Exp Med 183:147, 1996
22. Hayes MP, Wang J, Norcross MA: Regulation of interleukin-12 expression in human monocytes: Selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes. Blood 86:646, 1995
23. Snijders A, Hilkens CM, van der Pouw Kraan TC, Engel M, Aarden LA, Kapsenberg ML: Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J Immunol 156:1207, 1996
24. Van Deventer SJ, Buller HR, ten Cate JW, Sturk A, Pauw W: Endotoxaemia: An early predictor of septicaemia in febrile patients. Lancet 1:605, 1988
25. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G: Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on production of cytokines by human peripheral blood mononuclear cells: Priming for IL-12 and tumor necrosis factor a production. J Exp Med 181:537, 1995
26. Powrie F, Menon S, Coffman RL: Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 23:3043, 1993
27. Del-Pretc G, De-Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S: Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150:353, 1993
28. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041, 1993
29. O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML: Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222:482, 1995
30. Faist E, Mewes A, Strasser T, Walz A, Alkan S, Baker CC, Ertel W, Heberer G: Alteration of monocyte function following major injury. Arch Surg 123:287, 1988
31. Ayala A, Knotts JB, Ertel W, Perrin MM, Morrison MH, Chaudry IH: Role of interleukin 6 and transforming growth factor-β in the induction of depressed splenocyte responses following sepsis. Arch Surg 128:89, 1993
32. Junger WG, Hoyt DB, Liu FC, Loomis WH, Coimbra R: Immunosuppression after endotoxin shock: The result of multiple anti-inflammatory factors. J Trauma 40:702, 1996
33. DiPiro JT, Howdieshell TR, Goddard JK, Callaway DB, Hamilton RG, Mansberger AR: Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg 130:1159, 1995
34. DeWaal Malefyt R, Abrams J, Bennet B, Figdor CG, de Vries JE: Interleukin-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209, 1991
35. Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, Volk HD: Mechanism of endotoxin desensitization: Involvement of interleukin-10 and transforming growth factor β. J Exp Med 181:1887, 1995
36. Miller-Graziano CL, De AK, Kodys K: Altered IL-10 levels in trauma patients' M phi and T lymphocytes. J Clin Immunol 15:93, 1995
37. Napolitano LM, Campbell C: Polymicrobial sepsis following trauma inhibits interleukin-10 secretion and lymphocyte proliferation. J Trauma 39:104, 1995
38. Hoyt DB, Ozkan AN, Easter D, Pinney E: Isolation of an immunosuppressive trauma peptide and its relationship to fibronectin. J Trauma 28:907, 1988
39. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 263:5380, 1988
40. Knudsen PJ, Dinarello CA, Strom TB: Prostaglandins post-transcriptionally inhibit monocyte expression of interleukin-1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol 137:3189, 1986
41. Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, Shearer GM: Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721, 1993
42. Dries DJ, Jurkovich GJ, Maier RV, Clemmer TP, Struve SN, Weigelt JA, Stanford GG, Herr DL, Champion HR, Lewis FR: Effect of interferon gamma on infection-related death in patients with severe injuries: A randomized, double-blind, placebo-controlled trial. Arch Surg 129:1031, 1994